Author: Ng, Wern Hann; Liu, Xiang; Mahalingam, Suresh
Title: Development of vaccines for SARS-CoV-2 Cord-id: 9r2zow4f Document date: 2020_8_17
ID: 9r2zow4f
Snippet: COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies bei
Document: COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches.
Search related documents:
Co phrase search for related documents- live include and low vaccine: 1
- live vaccine and low vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- live vaccine and lung tissue: 1, 2, 3, 4
- live vaccine and lymph node: 1
- live vaccine immune response and low vaccine: 1
- live virus and low vaccine: 1, 2, 3, 4, 5, 6, 7
- live virus and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- live virus and lymph node: 1
- lung tissue and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date